Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients

Journal of Critical Care

Volumn 40, Issue , 2017, Pages 197-201

  Mihajlovic, Dunja ^a   Brkic, Snezana ^a   Uvelin, Arsen ^a   Draskovic, Biljana ^a   Vrsajkov, Vladimir ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Bacteremia; Presepsin; Sepsis; SeptiFast

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG; CALCITONIN; LIPOPOLYSACCHARIDE RECEPTOR; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN;

ABDOMINAL INFECTION; ADULT; AGED; APACHE; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER INFECTION; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEVER; HUMAN; LABORATORY TECHNIQUE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION SYSTEM; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIFAST; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; BLOOD; CRITICAL ILLNESS; EARLY DIAGNOSIS; EVALUATION STUDY; MIDDLE AGED; PREDICTIVE VALUE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; EARLY DIAGNOSIS; FEMALE; HUMANS; LIPOPOLYSACCHARIDE RECEPTORS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; ROC CURVE; YOUNG ADULT;

EID: 85020721725     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.04.008     Document Type: Article

References (35)

1. Angus, D.C., van der Poll, T., Severe sepsis and septic shock. N Engl J Med 369 (2013), 840–851.
2. Moore, L.J., McKinley, B.A., Turner, K., et al. The epidemiology of sepsis in general surgery patients. J Trauma 70:3 (2011), 672–680.
3. Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving sepsis campaign: international guidelines for Management of Severe Sepsis and Septic Shock. Intensive Care Med 39 (2012), 165–228.
4. Vincent, J.L., Opal, S.M., Marshall, J.C., et al. Sepsis definitions: time for change. The Lancet 381:9868 (2013), 774–775.
5. Garnacho-Montero, J., Ortiz-Leyba, C., Herrera-Melero, I., et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 61:2 (2008), 436–441.
6. Pierrakos, C., Vincent, J.L., Sepsis biomarkers: a review. Crit Care, 14, 2010, R15.
7. Becker, K.L., Nyle'n, E.S., White, J.C., et al. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89 (2004), 1512–1525.
8. Zou, Q., Wen, W., Zhang, X.C., Presepsin as a novel sepsis biomarker. World J Emerg Med, 5(1), 2014, 16.
9. Wu, J., Hu, L., Zhang, G., et al. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PLoS One, 10(7), 2015, e0133057.
10. Agilli, M., Sener, I., Yesildal, F., et al. A new marker for the diagnosıs of sepsis: presepsin. J Investig Biochem 1:1 (2012), 55–57.
11. Yaegashi, Y.S.K., Sato, N., Suzuki, Y., et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 11:5 (2005), 234–238.
12. Paolucci, M., Landini, M.P., Sambri, V., Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents 36 (2010), S6–S16.
13. Ecker, D.J., Sampath, R., Li, H., et al. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev Mol Diagn 10 (2010), 399–415.
14. Bravo, D., Blanquer, J., Tormo, M., et al. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis 15 (2011), 326–331.
15. Dark, P., Blackwood, B., Gates, S., McAuley, D., Perkins, G.D., McMullan, R., et al. Accuracy of LightCycler® SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis. Intensive Care Med 41:1 (Jan 1 2015), 21–33.
16. Bone, R., Balk, R., Cerra, F., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 101:6 (1992), 1644–1655.
17. Levy, M., Fink, M., Marshall, J., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:4 (2003), 1250–1256.
18. Calandra, T., Cohen, J., The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:7 (2005), 1538–1548.
19. Westh, H., Lisby, G., Breysse, F., et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 15:6 (2009), 544–551.
20. Vincent, J.L., Sakr, Y., Sprung, C.L., et al. Sepsis occurrence in acutely ill patients investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:2 (2006), 344–353.
21. Vincent, J.L., Rello, J., Marshall, J., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:21 (2009), 2323–2329.
22. Marshall, J.C., Reinhart, K., Biomarkers of sepsis. Crit Care Med 37 (2009), 2290–2298.
23. Huttunen, R., Aittoniemi, J., New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect 63:6 (2011), 407–419.
24. Hodgin, K.E., Moss, M., The epidemiology of sepsis. Curr Pharm Des 14 (2008), 1833–1839.
25. Skvarc, M., Stubljar, D., Rogina, P., et al. Non-culture-based methods to diagnose bloodstream infection: does it work?. European J Microbiol Immunol 3:2 (2013), 97–104.
26. de Guadiana Romualdo, L.G., Torrella, P.E., González, M.V., et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem 47:7 (2014), 505–508.
27. Mencacci, A., Leli, C., Cardaccia, A., et al. Procalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsis. PLoS One, 7(12), 2012, e53279.
28. Leli, C., Ferranti, M., Marrano, U., et al. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. J Med Microbiol 65:8 (2016), 713–719.
29. Novelli, G., Morabito, V., Ferretti, G., et al. Pathfast presepsin assay for early diagnosis of bacterial infections in surgical patients: preliminary study. Transplant Proc 45:7 (2013), 2750–2753.
30. Burdino, E., Ruggiero, T., Allice, T., et al. Combination of conventional blood cultures and the SeptiFast molecular test in patients with suspected sepsis for the identification of bloodstream pathogens. Diagn Microbiol Infect Dis 79:3 (2014), 287–292.
31. Paolucci, M., Stanzani, M., Melchionda, F., et al. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis 75 (2013), 130–134.
32. Pasqualini, L., Mencacci, A., Leli, C., Montagna, P., Cardaccia, A., Cenci, E., et al. Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol 50:4 (2012 Apr 1), 1285–1288.
33. Bouadma, L., Luyt, C.E., Tubach, F., et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375 (2010), 463–474.
34. Sankar, V., Webster, N.R., Clinical application of sepsis biomarkers. J Anesth 27:2 (2013), 269–283.
35. Okamura, Y., Yokoi, H., Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 412:23–24 (2011), 2157–2161.